SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-111818
Filing Date
2015-03-30
Accepted
2015-03-30 16:25:33
Documents
1
Group Members
JACOB GOTTLIEBJG ASSET, LLCVISIUM BALANCED MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO 4 d898741dsc13ga.htm SC 13G/A 109142
  Complete submission text file 0001193125-15-111818.txt   111000
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 15734779
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE - 22ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE - 22ND FLOOR NEW YORK NY 10019 212-474-8800
Visium Asset Management, LP (Filed by) CIK: 0001377452 (see all company filings)

IRS No.: 203313013 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A